Compare BOTJ & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOTJ | VNRX |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.4M | 31.9M |
| IPO Year | 2015 | 2012 |
| Metric | BOTJ | VNRX |
|---|---|---|
| Price | $19.97 | $0.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 5.2K | ★ 1.8M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $4,003,000.00 | $1,233,511.00 |
| Revenue This Year | N/A | $68.22 |
| Revenue Next Year | N/A | $382.75 |
| P/E Ratio | $14.39 | ★ N/A |
| Revenue Growth | 2.61 | ★ 59.10 |
| 52 Week Low | $12.95 | $0.17 |
| 52 Week High | $21.49 | $0.94 |
| Indicator | BOTJ | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 39.10 |
| Support Level | $17.60 | $0.17 |
| Resistance Level | $21.47 | $0.27 |
| Average True Range (ATR) | 0.51 | 0.02 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 39.59 | 31.96 |
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.